awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35759171-1FDF5F11-B642-45A1-8904-21BE2CAE09FB
Q35759171-1FDF5F11-B642-45A1-8904-21BE2CAE09FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759171-1FDF5F11-B642-45A1-8904-21BE2CAE09FB
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab
P2860
Q35759171-1FDF5F11-B642-45A1-8904-21BE2CAE09FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759171-1FDF5F11-B642-45A1-8904-21BE2CAE09FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ceba9f8f2ebc71ea40feb4b71602690980f0b42
P2860
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.